GlassScriptPhysician profile
Tonya L Phillips
NPI 1952323297
$16,705.55
in general payments reported to CMS, 2019-2025
62 companies · $2,655 in 2025
The $2,655 reported for 2025 was more than what 77% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,278 · 2020: $494 · 2021: $1,236 · 2022: $3,147 · 2023: $3,145 · 2024: $2,750 · 2025: $2,655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,550.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,450.96 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,921.34 | 2019-2025 | |
| Sk Life Science, INC. | $1,071.71 | 2020-2025 | |
| Ucb, INC. | $893.57 | 2019-2025 | Briviact, Nayzilam, Fintepla |
| Pfizer INC. | $845.18 | 2023-2025 | |
| Biogen, INC. | $817.80 | 2019-2025 | Tysabri, Vumerity, Skyclarys |
| Amgen INC. | $787.09 | 2019-2025 | Uplizna, Aimovig |
| Neurocrine Biosciences, INC. | $708.92 | 2019-2025 | Ingrezza, Ongentys |
| Eisai INC. | $618.58 | 2019-2025 | |
| Acadia Pharmaceuticals INC | $449.86 | 2019-2024 | Nuplazid |
| Lundbeck LLC | $445.64 | 2019-2025 | Vyepti |
| Mdd US Operations, LLC | $388.00 | 2022-2025 | Gocovri, Myobloc, Apokyn |
| Genzyme Corporation | $338.42 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $303.23 | 2019-2023 | Rytary |
| Emd Serono, INC. | $302.35 | 2019-2025 |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $297.98 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $244.73 | 2022 | |
| Alexion Pharmaceuticals, INC. | $236.27 | 2019-2024 | Ultomiris, Soliris |
| Avanir Pharmaceuticals, INC. | $225.82 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $213.60 | 2019-2022 | |
| Gt Medical Technologies, INC | $209.09 | 2021 | |
| Lilly USA, LLC | $208.99 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Argenx US, INC. | $200.55 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Teva Pharmaceuticals USA, INC. | $194.90 | 2019-2025 | Austedo Xr, Austedo, Austedo Xr |
| Acorda Therapeutics, INC | $189.20 | 2019 | |
| Adamas Pharmaceuticals, INC. | $172.09 | 2019-2021 | |
| Tanabe Pharma America, INC. | $137.69 | 2021-2024 | |
| Meditrina | $128.61 | 2023 | |
| Kyowa Kirin, INC. | $124.04 | 2019-2022 | |
| Neurelis, INC. | $112.78 | 2022-2024 | Valtoco |
| Catalyst Pharmaceuticals, INC. | $112.43 | 2022-2025 | Fycompa |
| Genentech USA, INC. | $95.87 | 2019-2024 | Ocrevus |
| Livanova USA, INC. | $95.57 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Tela Bio, INC. | $81.37 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Allergan, INC. | $80.36 | 2019-2022 | |
| Banner Life Sciences, LLC | $71.86 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $70.45 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $67.57 | 2023-2024 | Nuedexta, Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $63.91 | 2019 | |
| Celgene Corporation | $57.21 | 2021-2024 | Zeposia |
| Upsher-Smith Laboratories LLC | $54.09 | 2023 | |
| Ani Pharmaceuticals, INC. | $52.91 | 2023 | Purified Cortrophin Gel |
| Mallinckrodt Enterprises LLC | $50.56 | 2019 | |
| Averitas Pharma INC. | $50.29 | 2023-2025 | Qutenza |
| Jazz Pharmaceuticals INC. | $47.29 | 2021-2023 | Epidiolex |
| Janssen Pharmaceuticals, INC | $46.39 | 2021-2024 | Xarelto |
| Grifols USA, LLC | $44.67 | 2019 | |
| Merz Pharmaceuticals, LLC | $37.91 | 2025 | Xeomin, Ampyra, Inbrija |
| Corium, LLC | $37.67 | 2023 | Adlarity |
| Axsome Therapeutics, INC. | $33.05 | 2025 | Symbravo |
| Tg Therapeutics, INC. | $32.57 | 2025 | |
| Kedrion Biopharma, INC. | $28.85 | 2024 | Koate, Kedrab, Albuked |
| Vertical Pharmaceuticals, LLC | $27.20 | 2020 | |
| Zyla Life Sciences, INC. | $24.49 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $18.13 | 2022 | |
| Arbor Pharmaceuticals, INC. | $17.57 | 2022 | |
| Avion Pharmaceuticals | $17.16 | 2022 | |
| Abbott Laboratories | $14.34 | 2022 | |
| Alnylam Pharmaceuticals INC. | $12.89 | 2019 | |
| Greenwich Biosciences, INC. | $12.70 | 2019 | |
| Grt US Holding, INC. | $7.41 | 2022 | |
| Kinex Medical Company LLC | $1.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tonya Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.